NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NeuroPace Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.77+0.53 (+4.33%)
Close on Oct 19, 2026
- Market cap
- $435.51M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
+$2.36 (+22.67%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
NeuroPace Inc grew revenue 16.9% to $98.84M over the twelve months to Jun 30, 2026. Free cash flow was -$11.61M.
Revenue
$98.84M
+16.9% vs. a year earlier
Operating income
-$15.08M
TTM Q2 2026
Free cash flow
-$11.61M
TTM Q2 2026
EPS, diluted
-$0.57
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $435.51M
- P/E ratio
- –
- Price to sales
- 4.41
- Price to book
- 36.65
- Dividend yield
- 0.00%
- Free cash flow yield
- -2.67%
Fundamentals
- Revenue
- $98.84M
- Net income
- -$19.11M
- EPS, diluted
- -$0.57
- Free cash flow
- -$11.61M
- Book value per share
- $0.35
- Diluted shares
- 34M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$98.84M+16.9% YoY
Gross profit
$78.70M+20.8% YoY
Operating income
-$15.08M
Net income
-$19.11M
EPS, diluted
-$0.57
Free cash flow
-$11.61M
Reported periodTrailing twelve months